Fybogel Mebeverine Granules for Oral Suspension Ispaghula Husk 3.5g Mebeverine Hydrochloride 135mg Irlanda - inglese - HPRA (Health Products Regulatory Authority)

fybogel mebeverine granules for oral suspension ispaghula husk 3.5g mebeverine hydrochloride 135mg

reckitt benckiser ireland ltd - mebeverine hydrochloride; ispaghula husks - granules for oral suspension - 3.5 g/135 milligram(s) - bulk-forming laxatives; ispaghula, combinations

Metamucil Wild Berry Smooth psyllium husk powder Australia - inglese - Department of Health (Therapeutic Goods Administration)

metamucil wild berry smooth psyllium husk powder

procter & gamble australia pty ltd - psyllium husk powder, quantity: 568 mg/g - oral liquid, powder for - excipient ingredients: brilliant blue fcf; allura red ac; citric acid; malic acid; aspartame; maltodextrin; acesulfame potassium; flavour - management of chronic constipation; constipation in irritable bowel syndrome; as adjunctive therapy in diverticular disease; in the bowel management of patients with haemorrhoids; and for constipation during pregnancy, convalescence and senility. diets low in saturated fat and cholesterol that include 7 grams of soluble fibre from psyllium husk, as in metamucil, may lower cholesterol levels. reductions in cholesterol may contribute to reducing the risk of heart disease.

METAMUCIL LEMON LIME SMOOTH psyllium husk powder 578mg/g jar Australia - inglese - Department of Health (Therapeutic Goods Administration)

metamucil lemon lime smooth psyllium husk powder 578mg/g jar

procter & gamble australia pty ltd - psyllium husk powder, quantity: 577.993 mg/g - oral liquid, powder for - excipient ingredients: sunset yellow fcf; quinoline yellow; citric acid; maltodextrin; aspartame; flavour - management of chronic constipation; constipation in irritable bowel syndrome; as adjunctive therapy in diverticular disease; in the bowel management of patients with haemorrhoids; and for constipation during pregnancy, convalescence and senility.,diets low in saturated fat and cholesterol that include 7 grams of soluble fibre from psyllium husk, as in metamucil, may lower cholesterol levels. reductions in cholesterol may contribute to reducing the risk of heart disease. new indications 24 june 2008: to restore and maintain regularity. to help lower cholesterol levels.,metamucil improves your health in 5 ways:,1. is a daily cleanser for your insides,2. assists in body's natural toxin removal process due to its cleansing effect,3. feel lighter,4. feel more active,5. maintains healthy cholesterol levels

METAMUCIL ORANGE SMOOTH psyllium husk powder 535mg/g jar Australia - inglese - Department of Health (Therapeutic Goods Administration)

metamucil orange smooth psyllium husk powder 535mg/g jar

procter & gamble australia pty ltd - psyllium husk powder, quantity: 535 mg/g - oral liquid, powder for - excipient ingredients: sunset yellow fcf; maltodextrin; aspartame; citric acid; purified water; flavour - management of chronic constipation; constipation in irritable bowel syndrome; as adjunctive therapy in diverticular disease; in the bowel management of patients with haemorrhoids; and for constipation during pregnancy, convalescence and senility. new indication as at 14 april 2002: diets low in saturated fat and cholestrol that include 7 grams of soluble fibre from psyllium husk, as in metamucil, may lower cholesterol levels. reductions in cholesterol may contribute to reducing the risk of heart disease. new indications 24 june 2008: to restore and maintain regularity. to help lower cholesterol levels.,metamucil improves your health in 5 ways:,1. is a daily cleanser for your insides,2. assists in body's natural toxin removal process due to its cleansing effect,3. feel lighter,4. feel more active,5. maintains healthy cholesterol levels

NIGROSPORA SPHAERICA injection, solution Stati Uniti - inglese - NLM (National Library of Medicine)

nigrospora sphaerica injection, solution

nelco laboratories, inc. - khuskia oryzae (unii: vk8c112wts) (khuskia oryzae - unii:vk8c112wts) - khuskia oryzae 40000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

NIGROSPORA SPHAERICA- nigrospora shaerica injection, solution Stati Uniti - inglese - NLM (National Library of Medicine)

nigrospora sphaerica- nigrospora shaerica injection, solution

nelco laboratories, inc. - khuskia oryzae (unii: vk8c112wts) (khuskia oryzae - unii:vk8c112wts) - khuskia oryzae 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t